28 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• Tonix Pharmaceuticals, Inc. TNXP shares moved upwards by 73.3% to $1.56 during Thursday's pre-market session.
• Allied Healthcare Prods, Inc. AHPI shares moved upwards by 40.8% to $5.18.
• Co-Diagnostics, Inc. CODX stock increased by 32.9% to $11.83. The most recent rating by HC Wainwright & Co., on February 24, is at Buy, with a price target of $4.00.
• Novavax, Inc. NVAX shares surged 26.9% to $11.70.
• Lianluo Smart, Inc. LLIT shares moved upwards by 24.4% to $1.12.
• Moderna, Inc. MRNA shares rose 23.8% to $36.10. The most recent rating by Needham, on February 26, is at Buy, with a price target of $35.00.
• Vaxart, Inc. VXRT shares surged 21.2% to $2.00.
• BioCryst Pharmaceuticals, Inc. BCRX shares surged 19.0% to $3.01.
• Teladoc Health, Inc. TDOC stock surged 15.4% to $134.90. The most recent rating by Cantor Fitzgerald, on February 27, is at Neutral, with a price target of $135.00.
• Inovio Pharmaceuticals, Inc. INO stock increased by 14.5% to $4.57. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
• BOQI International, Inc. BIMI stock increased by 14.1% to $4.60.
• Aethlon Medical, Inc. AEMD shares increased by 13.8% to $2.15.
• Vir Biotechnology, Inc. VIR shares increased by 10.7% to $38.70. The most recent rating by JP Morgan, on February 04, is at Neutral, with a price target of $26.00.
• Gilead Sciences, Inc. GILD shares rose 6.9% to $79.84. The most recent rating by Bernstein, on February 06, is at Market Perform, with a price target of $70.00.
• Sorrento Therapeutics, Inc. SRNE stock surged 5.4% to $2.36.
• Correvio Pharma, Inc. CORV shares increased by 4.8% to $0.36. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
• Qiagen, Inc. QGEN stock moved upwards by 4.6% to $36.70. The most recent rating by CFRA, on February 06, is at Hold, with a price target of $38.00.
• Cleveland BioLabs, Inc. CBLI stock rose 4.4% to $3.54.
• Enlivex Therapeutics, Inc. ENLV stock rose 4.3% to $8.87. The most recent rating by H.C. Wainwright, on January 09, is at Buy, with a price target of $20.00.
• Regeneron Pharmaceuticals, Inc. REGN shares surged 3.1% to $472.00. The most recent rating by Credit Suisse, on February 26, is at Outperform, with a price target of $510.00.

Losers

• Cocrystal Pharma, Inc. COCP stock fell 12.4% to $1.55 during Thursday's pre-market session.
• Galapagos, Inc. GLPG shares fell 6.2% to $219.37. The most recent rating by Nomura, on February 26, is at Buy, with a price target of $290.00.
• Endo International, Inc. ENDP shares plummeted 5.8% to $5.98. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $7.00.
• SELLAS Life Sciences, Inc. SLS stock declined 5.3% to $2.50.
• Genprex, Inc. GNPX stock fell 5.0% to $4.54.
• Advaxis, Inc. ADXS shares fell 5.0% to $0.85.
• Guardion Health Sciences, Inc. GHSI stock decreased by 4.2% to $0.29.
• Amarin Corp, Inc. AMRN shares decreased by 3.6% to $15.69. The most recent rating by Oppenheimer, on February 26, is at Underperform, with a price target of $12.00.